The IFoA’s Longevity Catalysts Membership Interest Group (MIG) is thrilled to be able to host a panel discussion looking at the exciting and very relevant area of vaccine development and the role it may have as a longevity catalyst. Please join Adam Ritchie, Senior Project Manager for the Jenner Institute, and Nicola Oliver, co-founder of Medical Intelligence at 14:00 (BST) on Wednesday 9 June for the discussion where we will consider the advancements made in vaccine development for COVID-19 and the implications this could have both for other viruses and as therapeutics for other diseases such as cancer. The panel will be hosted by Caroline Roberts, Longevity Actuary at Phoenix Group and a member of the MIG’s managing committee. Please email the MIG inbox to sign up, after which you will be provided with a MS Teams link to the event. We look forward to seeing you there. Please note that by emailing you are agreeing for the MIG to use your email address for further correspondence about this and future events – to opt out please note this in your email.